Literature DB >> 14648860

Impact of comorbidity on the outcome of laryngeal squamous cancer.

Vinidh Paleri1, Richard G Wight, Gareth R Davies.   

Abstract

BACKGROUND: Comorbidity has been shown to be a determinant in treatment selection and survival in various cancers. We have previously shown that the Adult Comorbidity Evaluation-27 index is applicable in a United Kingdom setting, and the process of comorbidity grading by retrospective notes evaluation is an accurate and reliable process.
METHODS: The impact of comorbidity and other factors on survival was examined retrospectively in a cohort of 180 patients with laryngeal squamous cell cancer.
RESULTS: This study shows for the first time that the higher comorbidity burden seen in supraglottic cancers in contrast to glottic tumors might account for the poorer prognosis. This study also externally validates the composite comorbidity-TNM staging system described by Piccirillo and shows the composite system to be a better predictor of outcome than TNM staging system alone.
CONCLUSIONS: Moderate and severe comorbidity have a greater and statistically significant impact on survival than the TNM staging system. Copyright 2003 Wiley Periodicals, Inc. Head Neck 25: 000-000, 2003

Entities:  

Mesh:

Year:  2003        PMID: 14648860     DOI: 10.1002/hed.10333

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  12 in total

1.  The future of the TNM staging system in laryngeal cancer: time for a debate?

Authors:  Alfio Ferlito; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-07-22       Impact factor: 2.503

2.  Disease control using low-dose-rate brachytherapy is unaffected by comorbid severity in oral cancer patients.

Authors:  R Yoshimura; H Shibuya; K Hayashi; K Toda; H Watanabe; M Miura
Journal:  Br J Radiol       Date:  2011-01-11       Impact factor: 3.039

3.  The effect of age on survival and quality of life in elderly head and neck cancer patients: a long-term prospective study.

Authors:  Marc P van der Schroeff; Wynia Derks; Gerrit Jan Hordijk; Rob J de Leeuw
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-11-11       Impact factor: 2.503

4.  Age-adjusted comorbidity and survival in locally advanced laryngeal cancer.

Authors:  Collin F Mulcahy; Abdallah S R Mohamed; Aasheesh Kanwar; Katherine A Hutcheson; Alokananda Ghosh; David Vock; Randal S Weber; Stephen Y Lai; Gary Brandon Gunn; Mark Zafereo; William H Morrison; Renata Ferrarotto; Adam S Garden; David I Rosenthal; Clifton D Fuller
Journal:  Head Neck       Date:  2018-05-13       Impact factor: 3.147

5.  Comorbidity, human papillomavirus infection and head and neck cancer survival in an ethnically diverse population.

Authors:  Ashish A Ankola; Richard V Smith; Robert D Burk; Michael B Prystowsky; Catherine Sarta; Nicolas F Schlecht
Journal:  Oral Oncol       Date:  2013-07-25       Impact factor: 5.337

Review 6.  Treatment of older patients with head and neck cancer: a review.

Authors:  Noam A VanderWalde; Mary Fleming; Jared Weiss; Bhishamjit S Chera
Journal:  Oncologist       Date:  2013-05-01

7.  Prognostic Importance of Comorbidity and the Association Between Comorbidity and p16 in Oropharyngeal Squamous Cell Carcinoma.

Authors:  S Andrew Skillington; Dorina Kallogjeri; James S Lewis; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-06-01       Impact factor: 6.223

8.  Cardiac comorbidity in head and neck cancer patients and its influence on cancer treatment selection and mortality: a prospective cohort study.

Authors:  Roland Simeoni; Kerstin Breitenstein; Dirk Eßer; Orlando Guntinas-Lichius
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-18       Impact factor: 2.503

9.  Validity of the age-adjusted charlson comorbidity index on clinical outcomes for patients with nasopharyngeal cancer post radiation treatment: a 5-year nationwide cohort study.

Authors:  Ching-Chieh Yang; Po-Chun Chen; Chia-Wen Hsu; Shih-Lun Chang; Ching-Chih Lee
Journal:  PLoS One       Date:  2015-01-24       Impact factor: 3.240

10.  The Characteristics and Survival Outcomes in Patients Aged 70 Years and Older with Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era.

Authors:  Ya-Nan Jin; Wang-Jian Zhang; Xiu-Yu Cai; Mei-Su Li; Wayne R Lawrence; Si-Yang Wang; Dong-Mei Mai; Yu-Yun Du; Dong-Hua Luo; Hao-Yuan Mo
Journal:  Cancer Res Treat       Date:  2018-02-06       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.